GBS Inc.
GBS Inc. (GBS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GBS · as of Jun 8, 2026
Key Statistics
Explore GBS Inc. Data
gbs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
gbs competitorsGBS
BIOC
BIOL
LFLY
OSA
OTRKStock Performance
Full HistoryAbout GBS Inc.
GBS Inc. Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film tr…
what is gbs inc. · gbs stock overview · gbs inc. company profile · who is gbs inc. ceo · gbs NASDAQ · gbs inc. headquarters · gbs inc. business segments
About Stock Overview & Key Data
GBS Inc. (GBS) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Dec 23, 2020. As of the latest trading session, GBS stock price is $0.47, with a market capitalization of $433,577. The stock has returned -32.40% over the past 12 months and -60.24% year-to-date.
According to 1 Wall Street analysts, the consensus rating for GBS Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, GBS Inc. reported revenue of $3.1M and net income of -$10.6M. For detailed data — including GBS Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GBS Inc. (GBS) stock price is $0.47. The stock is traded on NASDAQ under the ticker symbol GBS. The 52-week range is $0.36 – $2.89.